The FDA identifies its first drug shortage due to coronavirus but won’t name the medicine
For the first time since the coronavirus outbreak began, the Food and Drug Administration has reported a shortage of a medicine due to a manufacturing “issue” with an active pharmaceutical ingredient. However, the agency did not disclose the name of the medicine, prompting criticism over concerns the lack of information can make it difficult to plan for patient needs.
In a statement issued Thursday night, the FDA explained that an unnamed manufacturer reported a shortage, but did not provide any further details. The statement added that “it is important to note that there are other alternatives that can be used by patients,” and that the FDA is working with the company and other manufacturers to mitigate the shortage.
